Daniel A. Spyker

10.2k total citations · 12 hit papers
110 papers, 7.2k citations indexed

About

Daniel A. Spyker is a scholar working on Emergency Medicine, Pharmacology and Pharmacology. According to data from OpenAlex, Daniel A. Spyker has authored 110 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Emergency Medicine, 21 papers in Pharmacology and 17 papers in Pharmacology. Recurrent topics in Daniel A. Spyker's work include Poisoning and overdose treatments (50 papers), Forensic Toxicology and Drug Analysis (15 papers) and Antibiotics Pharmacokinetics and Efficacy (14 papers). Daniel A. Spyker is often cited by papers focused on Poisoning and overdose treatments (50 papers), Forensic Toxicology and Drug Analysis (15 papers) and Antibiotics Pharmacokinetics and Efficacy (14 papers). Daniel A. Spyker collaborates with scholars based in United States, Canada and Russia. Daniel A. Spyker's co-authors include James B. Mowry, Louis R. Cantilena, Alvin C. Bronstein, Barry H. Rumack, Daniel E. Brooks, David D. Gummin, Jody L. Green, Marsha Ford, Richard C. Dart and Jay L. Schauben and has published in prestigious journals such as American Journal of Psychiatry, American Journal of Clinical Nutrition and IEEE Transactions on Automatic Control.

In The Last Decade

Daniel A. Spyker

108 papers receiving 6.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st Annual Report

2014 585 citations James B. Mowry, Daniel A. Spyker et al. Clinical Toxicology profile →
2016 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th Annual Report

2017 394 citations David D. Gummin, James B. Mowry et al. Clinical Toxicology profile →
2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32nd Annual Report

2015 350 citations James B. Mowry, Daniel A. Spyker et al. Clinical Toxicology profile →
2012 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th Annual Report

2013 338 citations James B. Mowry, Daniel A. Spyker et al. Clinical Toxicology profile →
2011 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report

2012 328 citations Alvin C. Bronstein, Daniel A. Spyker et al. Clinical Toxicology profile →
2015 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 33rd Annual Report

2016 282 citations James B. Mowry, Daniel A. Spyker et al. Clinical Toxicology profile →
2017 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 35th Annual Report

2018 260 citations David D. Gummin, James B. Mowry et al. Clinical Toxicology profile →
2018 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th Annual Report

2019 258 citations David D. Gummin, James B. Mowry et al. Clinical Toxicology profile →
2019 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 37th Annual Report

2020 248 citations David D. Gummin, James B. Mowry et al. Clinical Toxicology profile →
2020 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 38th Annual Report

2021 206 citations David D. Gummin, James B. Mowry et al. Clinical Toxicology profile →
2021 Annual Report of the National Poison Data System ^© (NPDS) from America’s Poison Centers: 39th Annual Report

2022 109 citations David D. Gummin, James B. Mowry et al. Clinical Toxicology profile →
2022 Annual Report of the National Poison Data System ^® (NPDS) from America’s Poison Centers ^® : 40th Annual Report

2023 101 citations David D. Gummin, James B. Mowry et al. Clinical Toxicology profile →

Peers

Countries citing papers authored by Daniel A. Spyker

Since Specialization

Citations

This map shows the geographic impact of Daniel A. Spyker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Spyker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Spyker more than expected).

Fields of papers citing papers by Daniel A. Spyker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Spyker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Spyker. The network helps show where Daniel A. Spyker may publish in the future.

Co-authorship network of co-authors of Daniel A. Spyker

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Spyker. A scholar is included among the top collaborators of Daniel A. Spyker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Spyker. Daniel A. Spyker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2024 Annual report of the National Poison Data System® (NPDS) from America’s Poison Centers ^® : 42nd annual report 2025 ·Clinical Toxicology ·Michael C. Beuhler, Ryan Feldman, David D. Gummin, James B. Mowry, (unknown), (unknown), (unknown), (unknown), Daniel A. Spyker, Alvin C. Bronstein	0
2	2023 Annual Report of the National Poison Data System® (NPDS) from America’s Poison Centers®: 41st Annual Report 2024 ·Clinical Toxicology ·David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, (unknown), Ryan Feldman, (unknown), (unknown), Alvin C. Bronstein, Carol DesLauriers	27
3	Outcomes of Patients With Premature Discontinuation of the 21-h Intravenous N-Acetylcysteine Protocol After Acute Acetaminophen Overdose 2016 ·Journal of Emergency Medicine ·(unknown), Mark Yarema, Marco L.A. Sivilotti, David W. Johnson, Alberto Nettel‐Aguirre, (unknown), Benoît Bailey, Richard C. Dart, Kennon Heard, Daniel A. Spyker, Barry H. Rumack	8
4	Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens 2015 ·The Journal of Clinical Pharmacology ·Daniel A. Spyker, Robert Riesenberg, James V. Cassella	13
5	Safety and Tolerability of Inhaled Loxapine in Subjects with Asthma and Chronic Obstructive Pulmonary Disease—Two Randomized Controlled Trials 2014 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Nicholas J. Gross, Leon S. Greos, Eli O. Meltzer, Selwyn Spangenthal, Robert Fishman, Daniel A. Spyker, James V. Cassella	19
6	Loxapine delivered as a thermally generated aerosol does not prolong QTc in a thorough QT/QTc study in healthy subjects 2013 ·The Journal of Clinical Pharmacology ·Daniel A. Spyker, (unknown), Eugene R. Heyman, James V. Cassella	21
7	The Pharmacokinetics and Pharmacodynamics of Zaleplon Delivered as a Thermally Generated Aerosol in a Single Breath to Volunteers 2012 ·The Journal of Clinical Pharmacology ·Michael J. Avram, Daniel A. Spyker, John H. Kehne, James V. Cassella	3
8	Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo‐controlled clinical trial with inhaled loxapine 2012 ·Bipolar Disorders ·Joseph A. Kwentus, Robert Riesenberg, (unknown), (unknown), Michael H. Allen, Robert Fishman, Daniel A. Spyker, John H. Kehne, James V. Cassella	75
9	Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine 2011 ·The British Journal of Psychiatry ·Michael D. Lesem, Tram Tran-Johnson, Robert Riesenberg, David Feifel, Michael H. Allen, Robert Fishman, Daniel A. Spyker, John H. Kehne, James V. Cassella	90
10	Comparison of the 20-Hour Intravenous and 72-Hour Oral Acetylcysteine Protocols for the Treatment of Acute Acetaminophen Poisoning 2009 ·Annals of Emergency Medicine ·Mark Yarema, David W. Johnson, R Berlin, Marco L.A. Sivilotti, Alberto Nettel‐Aguirre, Rollin Brant, Daniel A. Spyker, Benoît Bailey, Dominic Chalut, Jacques Lee, Amy C. Plint, Roy Purssell, Tim Rutledge, (unknown), Ian G. Stiell, Margaret Thompson, (unknown), Richard C. Dart, Barry H. Rumack	74
11	2008 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 26th Annual Report 2009 ·Clinical Toxicology ·Alvin C. Bronstein, Daniel A. Spyker, Louis R. Cantilena, Jody L. Green, Barry H. Rumack, Sandra Giffin	329
12	2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report 2008 ·Clinical Toxicology ·Alvin C. Bronstein, Daniel A. Spyker, Louis R. Cantilena, Jody L. Green, Barry H. Rumack, Stuart E. Heard	301
13	Ultra-Fast Absorption of Amorphous Pure Drug Aerosols via Deep Lung Inhalation 2006 ·Journal of Pharmaceutical Sciences ·Joshua D. Rabinowitz, Peter Lloyd, Patrik Munzar, (unknown), (unknown), (unknown), (unknown), Daniel A. Spyker, (unknown), James V. Cassella	53
14	Oxycodone Involvement in Drug Abuse Deaths: A DAWN-Based Classification Scheme Applied to an Oxycodone Postmortem Database Containing Over 1000 Cases 2003 ·Journal of Analytical Toxicology ·E. J. Cone, Reginald V. Fant, (unknown), (unknown), (unknown), Robert F. Reder, Daniel A. Spyker, J. David Haddox	78
15	Assessment and reporting of clinical pharmacology information in drug labeling 2000 ·Clinical Pharmacology & Therapeutics ·Daniel A. Spyker, Emily Harvey, (unknown), (unknown), Barry H. Rumack, Carl C. Peck, (unknown), Raymond L. Woosley, D. R. Abernethy, Louis R. Cantilena	18
16	Behavioral treatment of phobic avoidance in multiple chemical sensitivity 1994 ·Journal of Behavior Therapy and Experimental Psychiatry ·Riccardo Guglielmi, Daniel J. Cox, Daniel A. Spyker	58
17	Toxicodynamic approach to management of the poisoned patient 1988 ·Journal of Emergency Medicine ·Daniel A. Spyker, Anil Minocha	1
18	Fatal Transcutaneous Iron Intoxication 1988 ·Journal of Burn Care & Rehabilitation ·(unknown), David E. Bruns, Daniel A. Spyker, (unknown), Richard F. Edlich	3
19	Generalized Convulsions as the Presenting Sign of Amoxapine Intoxication 1984 ·Clinical Pediatrics ·Alan D. Rogol, Robert Schoumacher, Daniel A. Spyker	6
20	A Comprehensive Information System for Emergency Medical Services. 1981 ·PubMed Central ·Anne Ahtikoski, Daniel A. Spyker, (unknown), Ernst O. Attinger	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact